NATO
APTSIAURI
PROFESORA TITULAR DE UNIVERSIDAD
MARÍA TERESA
CABRERA CASTILLO
CATEDRÁTICA DE UNIVERSIDAD
Publicaciones en las que colabora con MARÍA TERESA CABRERA CASTILLO (15)
2016
-
Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance
Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59
2013
-
MHC class I antigens in malignant cells: Immune escape and response to immunotherapy
Springer New York, pp. 1-51
-
MHC class i antigens and the tumor microenvironment
The Tumor Immunoenvironment (Springer Netherlands), pp. 253-286
2012
-
Cancer immune escape: Implications for immunotherapy, Granada, Spain, October 3-5, 2011
Cancer Immunology, Immunotherapy
2011
-
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846
-
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Immunogenetics, Vol. 63, Núm. 2, pp. 65-71
2010
-
"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
International Journal of Cancer
2009
-
HLA and melanoma: Multiple alterations in HLA class i and II expression in human melanoma cell lines from ESTDAB cell bank
Cancer Immunology, Immunotherapy, Vol. 58, Núm. 9, pp. 1507-1515
2008
-
HLA class I expression, tumor escape and cancer progression
Current Cancer Therapy Reviews, Vol. 4, Núm. 2, pp. 105-110
-
Regressing and progressing metastatic lesions: Resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
Cancer Immunology, Immunotherapy
2007
-
International conference: Progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain
Cancer Immunology, Immunotherapy
-
MHC Class I Antigens and Immune Surveillance in Transformed Cells
International Review of Cytology, Vol. 256, pp. 139-189
-
Role of altered expression of HLA class i molecules in cancer progression
Advances in Experimental Medicine and Biology
2006
-
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma
Tissue Antigens, Vol. 68, Núm. 4, pp. 303-310
-
LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas
Immunogenetics, Vol. 58, Núm. 7, pp. 503-510